We discovered that RANKL/RANK can enhance CCL20 production by CRC cells (Fig. 4c), which is consistent with earlier research [24], demonstrating that RANKL/RANK is important in the immunological microenvironment of CRC. Here, CCL20 is linked to colorectal carcinoma.